1. Home
  2. HKD vs LXEO Comparison

HKD vs LXEO Comparison

Compare HKD & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HKD

AMTD Digital Inc. (every five of which represent two)

N/A

Current Price

$1.51

Market Cap

499.7M

Sector

Finance

ML Signal

N/A

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

N/A

Current Price

$5.49

Market Cap

486.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HKD
LXEO
Founded
2003
2017
Country
France
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
499.7M
486.1M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
HKD
LXEO
Price
$1.51
$5.49
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$18.60
AVG Volume (30 Days)
605.1K
700.3K
Earning Date
02-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
75.08
EPS
N/A
N/A
Revenue
N/A
$654,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$1.45
52 Week High
$5.47
$10.99

Technical Indicators

Market Signals
Indicator
HKD
LXEO
Relative Strength Index (RSI) 43.84 28.96
Support Level $1.34 $4.67
Resistance Level $1.69 $7.77
Average True Range (ATR) 0.09 0.48
MACD -0.02 -0.12
Stochastic Oscillator 8.65 10.26

Price Performance

Historical Comparison
HKD
LXEO

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment; hotel operations, hospitality and VIP services segment; media and entertainment services segment; and Strategic investments. The company generates maximum revenue from Digital solutions services segment, which provides its institutional and corporate clients with exclusive, paid access to enhance their investor communication, investor relations and corporate communication to potentially maximize their valuation, as well as providing digital solution services. Geographically, the company generates revenue from China, Hong Kong, Europe, Americas and Southeast Asia.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: